Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted therapeutics based on engineered proteins that bind EGFR

Targeted therapeutics based on engineered proteins that bind EGFR

US Patent 8524244 · Granted Sep 3, 2013

Estimated economic value: $269,034,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for evaluating genomic alterations2025
Therapeutic and diagnostic methods for cancer2025
Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containin2025
PD-L1 binding polypeptides for imaging2025
Fibronectin based scaffold domain proteins that bind PCSK92024
Methods of treating cancer2023
Therapeutic and diagnostic methods for cancer2023
Cyclic dinucleotides as sting agonists2023
Cyclic dinucleotides as sting agonists2022
Cyclic dinucleotides as sting agonists2022
Fibronectin binding domains with reduced immunogenicity2022
PET imaging with PD-L1 binding polypeptides2022